← Eichor
Study identifier: NCT05686473 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Psychoeducation of Parents to Children With FASD

Condition: Fetal Alcohol Spectrum Disorders · Behavior Problem · Adaptive Behavior  ·  Sponsor: Sorlandet Hospital HF

PhaseNA
Planned participants75
Who can joinAll sexes, 2 Years to 18 Years
Healthy volunteersNo

About this study

By longitudinal, prospective research in children and adolescents with Fetal Alcohol Spectrum Disorders (FASD) and their parents to explore the beneficial effects of participating in a standardized intervention program in order to treat and reduce the consequences of early brain damage. By using elements from international programs based on psychoeducation and parent training, the investigators aim to help parents to better understand and respond to the neurodevelopmental disabilities of their children, and thereby improving behavioral problems and self-regulation deficits.

This description comes directly from the study's public registry record.

Talk to the study team

Anne Cecilie Tveiten, PhD student  ·  +47-370-75750  ·  Anne.Cecilie.Tveiten@sshf.no

Gro CC Løhaugen, PhD  ·  +47-370-75750  ·  Gro.lohaugen@sshf.no

Always discuss trial participation with your own doctor first.

Locations (1)

Sørlandet HospitalArendal, NorwayRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05686473